The global polycystic ovarian syndrome treatment market size was valued at USD 3.94 billion in 2024 and is anticipated to grow from USD 4.16 billion in 2025 to reach USD 6.43 billion in 2033, growing at a CAGR of 5.61% during the forecast period (2025–2033).